Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
HC CLINIC TRIAL-EMBOLIC PROT SYST (CDM 62400003) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 30, 2026 , from http://ppman.hank.ai/transparency/procedure/62400003/by-state?code_type=CDM
“HC CLINIC TRIAL-EMBOLIC PROT SYST (CDM 62400003) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/62400003/by-state?code_type=CDM. Accessed
June 30, 2026 .
“HC CLINIC TRIAL-EMBOLIC PROT SYST (CDM 62400003) by State,” HANK Price Transparency ,
accessed June 30, 2026 ,
http://ppman.hank.ai/transparency/procedure/62400003/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
62400003 — Hc Clinic Trial-embolic Prot Syst
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$3,183
National median
$2,440 – $3,979
IQR (p25 – p75)
17
hospitals filing
3
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 62400003 (CDM), with interquartile range
State Median p25 p75
LA $47,523 $27,300 $59,500
MS $33,250 $31,500 $39,375
TX $2,918 $2,440 $3,687